Page last updated: 2024-08-22

flupenthixol and Parkinson Disease

flupenthixol has been researched along with Parkinson Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Carney, AE; Clarke, C; Pratt, WE1
Benazzouz, A; Bioulac, B; Bouali-Benazzouz, R; Chetrit, J; Froux, L; Gross, CE; Kadiri, N; Morin, S; Naudet, F; Taupignon, A1
Franch, O; Kurtis, MM1
Franco, V; Turner, RS1
Herrera-Marschitz, M; Olson, L; Olsson, D; Strömberg, I; Ungerstedt, U1

Other Studies

5 other study(ies) available for flupenthixol and Parkinson Disease

ArticleYear
Administration of neuropeptide Y into the rat nucleus accumbens shell, but not core, attenuates the motivational impairment from systemic dopamine receptor antagonism by α-flupenthixol.
    Neuroscience letters, 2023, 02-16, Volume: 797

    Topics: Animals; Dopamine; Dopamine Antagonists; Flupenthixol; Huntington Disease; Male; Motivation; Neuropeptide Y; Nucleus Accumbens; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, Dopamine

2023
Inhibiting subthalamic D5 receptor constitutive activity alleviates abnormal electrical activity and reverses motor impairment in a rat model of Parkinson's disease.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013, Sep-11, Volume: 33, Issue:37

    Topics: Action Potentials; Animals; Animals, Newborn; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Flupenthixol; In Vitro Techniques; Locomotion; Male; Neurons; Oxidopamine; Parkinson Disease; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D5; Statistics, Nonparametric; Subthalamic Nucleus

2013
Tardive syndrome and Parkinson's disease responsive to concomitant tetrabenazine and levodopa therapy.
    Parkinsonism & related disorders, 2011, Volume: 17, Issue:10

    Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Depression; Female; Flupenthixol; Humans; Levodopa; Movement Disorders; Parkinson Disease; Tetrabenazine

2011
Testing the contributions of striatal dopamine loss to the genesis of parkinsonian signs.
    Neurobiology of disease, 2012, Volume: 47, Issue:1

    Topics: Animals; Dopamine; Dopamine Antagonists; Dopaminergic Neurons; Female; Flupenthixol; Macaca; Male; Movement; Neostriatum; Parkinson Disease; Psychomotor Performance; Putamen; Reaction Time

2012
Adrenal medullary implants in the dopamine-denervated rat striatum. II. Acute behavior as a function of graft amount and location and its modulation by neuroleptics.
    Brain research, 1984, Apr-09, Volume: 297, Issue:1

    Topics: Adrenal Medulla; Animals; Disease Models, Animal; Flupenthixol; Haloperidol; Hydroxydopamines; Male; Oxidopamine; Parkinson Disease; Rats; Rats, Inbred Strains; Rotation

1984